-
Je něco špatně v tomto záznamu ?
Intersexual differences in inhibitory influence of trans-resveratrol on activity of cytochrome P450 2D2 in rats
O. Zendulka, J. Totusek, A. Sulcova
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
20027150
Knihovny.cz E-zdroje
- MeSH
- aromatické hydroxylasy antagonisté a inhibitory metabolismus MeSH
- dextromethorfan chemie metabolismus MeSH
- dextrorfan chemie metabolismus MeSH
- inhibitory cytochromu P450 MeSH
- inhibitory enzymů farmakologie MeSH
- játra účinky léků metabolismus MeSH
- krysa rodu rattus MeSH
- pohlavní dimorfismus MeSH
- potkani Wistar MeSH
- stilbeny farmakologie MeSH
- systém (enzymů) cytochromů P-450 metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: Differences in the metabolism between males and females have been seen over time. Hormonal regulation of cytochrome P450 activity is understood to be involved. Trans-resveratrol (RES) is an estrogenically active plant polyphenol with many protective biological activities including neuroprotection. The present report studied the influence of sex and RES on variances in rat's cytochrome P450 2D2 hepatic metabolic activity. METHODS AND DESIGN: Isolated perfused rat liver was used for determination of cytochrome P450 2D2 activity. Wistar albino rats of both sexes were treated with RES at the dose of 5 mg/kg/day for 10 days prior to liver isolation. Levels of marker substance dextromethorphan (DEM) and its 2D2 specific metabolite dextrorphan (DEX) were measured during perfusion. The metabolic ratios (DEM/DEX) and the levels of DEM and DEX in perfusate were compared. RESULTS: In the controls, the activity of CYP2D2 was found to be higher in male rats compared to females. RES produced inhibition of CYP2D2, expressed by significant changes of both DEM and DEX levels in males and significant increase of only DEM levels in females. There were no gender changes in DEX levels in RES treated animals whilst DEM levels were significantly increased during the whole perfusion in females. CONCLUSION: The results confirmed gender differences in the metabolic activity of CYP450 2D2 with a higher rate in male rats. RES acted as an inhibitor, however again with greater impact in males than in females. This metabolic divergence could be a cause for different sensitivity or even toxicity of drugs metabolized by the CYP450 2D2.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025390
- 003
- CZ-PrNML
- 005
- 20130128192726.0
- 007
- ta
- 008
- 120816s2009 sw f 000 0#eng||
- 009
- AR
- 035 __
- $a (PubMed)20027150
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Zendulka, Ondřej. $7 xx0234689 $u Department of Pharmacology, Masaryk University, Brno, Czech Republic. zendulka@med.muni.cz
- 245 10
- $a Intersexual differences in inhibitory influence of trans-resveratrol on activity of cytochrome P450 2D2 in rats / $c O. Zendulka, J. Totusek, A. Sulcova
- 520 9_
- $a OBJECTIVES: Differences in the metabolism between males and females have been seen over time. Hormonal regulation of cytochrome P450 activity is understood to be involved. Trans-resveratrol (RES) is an estrogenically active plant polyphenol with many protective biological activities including neuroprotection. The present report studied the influence of sex and RES on variances in rat's cytochrome P450 2D2 hepatic metabolic activity. METHODS AND DESIGN: Isolated perfused rat liver was used for determination of cytochrome P450 2D2 activity. Wistar albino rats of both sexes were treated with RES at the dose of 5 mg/kg/day for 10 days prior to liver isolation. Levels of marker substance dextromethorphan (DEM) and its 2D2 specific metabolite dextrorphan (DEX) were measured during perfusion. The metabolic ratios (DEM/DEX) and the levels of DEM and DEX in perfusate were compared. RESULTS: In the controls, the activity of CYP2D2 was found to be higher in male rats compared to females. RES produced inhibition of CYP2D2, expressed by significant changes of both DEM and DEX levels in males and significant increase of only DEM levels in females. There were no gender changes in DEX levels in RES treated animals whilst DEM levels were significantly increased during the whole perfusion in females. CONCLUSION: The results confirmed gender differences in the metabolic activity of CYP450 2D2 with a higher rate in male rats. RES acted as an inhibitor, however again with greater impact in males than in females. This metabolic divergence could be a cause for different sensitivity or even toxicity of drugs metabolized by the CYP450 2D2.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a aromatické hydroxylasy $x antagonisté a inhibitory $x metabolismus $7 D001189
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
- 650 _2
- $a dextromethorfan $x chemie $x metabolismus $7 D003915
- 650 _2
- $a dextrorfan $x chemie $x metabolismus $7 D003917
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a játra $x účinky léků $x metabolismus $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a pohlavní dimorfismus $7 D012727
- 650 _2
- $a stilbeny $x farmakologie $7 D013267
- 650 _2
- $a inhibitory cytochromu P450 $7 D065607
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Totušek, Jiří, $d 1945- $7 xx0055061
- 700 1_
- $a Šulcová, Alexandra, $d 1945- $7 jn20000402920
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 30 Suppl 1(2009), s. 88-91
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20027150 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20130128192908 $b ABA008
- 999 __
- $a ok $b bmc $g 947432 $s 782736
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2009 $b 30 Suppl 1 $d 88-91 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20120816/10/02